CLBS receives fast track designation for diabetes drug Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes | Caladrius http://www.caladrius.com/press-release/fda-fast-track-designation-for-clbs03-to-treat-recent-onset-type-1-diabetes/